Abstract Objective: To assess the efficacy and tolerability of acetyl-L-carnitine (levacecarnine
acidophilus produces SCFAs like acetate, which activate Intercellular adhesion molecule-3-Grabbing Non-integrin Receptor 3 (SIGNR3) receptor on dendritic cells, suppressing IL-6/STAT3 and RORt pathways to inhibit Th17 differentiation while promoting Treg expansion, helping restore immune balance ( L.plantarum and A.muciniphila secrete metabolites that bind TLR2, downregulating NF-B to block the IL-23/Th17 axis, Additionally, A
Benefits gained during therapy may gradually diminish, but there's no rebound suppression
This does not mean it is approved or recommended as a sleep treatment
Control solutions were composed of carnitine standards (Cambridge Isotope Laboratory, Tewksbury, MA, USA) and quality control products
Precautions: If any adverse symptoms such as rash, swelling or itchiness arise, stop use and consult with your dermatologist